Disclaimer: MDS does not support, endorse or recommend applications listed in this database. They are listed as a courtesy, and include contact information for the developer or company responsible for the application creation.

Main Content

Redenlab

Target population: Patients with Parkinson's Disease, Chorea, Atypical Parkinson syndromes/Parkinson Plus

Measures: Speech

Clinical support: Monitoring

Redenlab’s technology aims to enhance decision making in clinical trials by providing objective and meaningful measurement of speech and language in the clinic and at home. It is based on 15+ years of clinical research and more than 200 peer-reviewed studies.

The Redenlab software suite uses audio capture and storage methods alongside quality management systems designed to meet the strict privacy and data sovereignty requirements of the health and medical clinical trial environment. It provides capacity for onboarding patients and study subjects, integration with Redenlab’s cloud-based data management portal, study, site and session selection based on user requirements.

Languages: English, French, German, Dutch, Polish, Portuguese, Spanish, Italian

Platform: Desktop, Tablet, Mobile Phone (iPhone, Android, Other)

User interfaces: Patients, Research study personnel, Doctors, Therapists

Additional Features:

Unlimited amount of subjects
Control data available
Database generation
Storage on Amazon Web Services (AWS), North America
Data ownership determined by conditions of use
Support for usage/test-setting/analysis. Additional cost.

For more information:
https://redenlab.com/
info@redenlab.com